We bought this land in anticipation of future growth and expansion. It's premature for Abbott to make any announcement regarding the future development or use of the land.
We are confident we have freedom to operate. With respect to Guidant's product, it would be inappropriate for us to comment.
Abbott has no intention of making any significant changes to the Guidant vascular facilities or employee base. We look forward to welcoming the Guidant vascular and endovascular teams.
We're very interested in acquiring Guidant's vascular business. If this acquisition of Guidant's vascular business were to go through, it would significantly enhance our vascular business.
None of these are material to this transaction.
We forged both of those agreements so that Abbott's vascular business will have some significant growth opportunities in either situation.
We are confident that Abbott will enjoy the full benefits of the acquisition.
